Similar articles

• Cerebrocortical modulation of S2-receptors and turnover rate of 5-hydroxytryptamine in ischemia.

  Wroblewska B, Kumami K, Cvejic V, Mrsulja BB, Spatz M. Wroblewska B, et al. Neurochem Res. 1987 Jan;12(1):21-5. doi: 10.1007/BF00971359. Neurochem Res. 1987. PMID: 3574586
• Effect of endogenous central nervous system depressants in ischemic cerebral edema of gerbils.

  Abe K, Abe T, Klatzo I, Spatz M. Abe K, et al. Adv Neurol. 1980;28:429-41. Adv Neurol. 1980. PMID: 7457257 No abstract available.
• Ischemic modification of cerebrocortical membranes: 5-hydroxytryptamine receptors, fluidity, and inducible in vitro lipid peroxidation.

  Villacara A, Kumami K, Yamamoto T, Mrsulja BB, Spatz M. Villacara A, et al. J Neurochem. 1989 Aug;53(2):595-601. doi: 10.1111/j.1471-4159.1989.tb07375.x. J Neurochem. 1989. PMID: 2746237
• 5-Hydroxytryptamine receptors.

  Peroutka SJ. Peroutka SJ. J Neurochem. 1993 Feb;60(2):408-16. doi: 10.1111/j.1471-4159.1993.tb03166.x. J Neurochem. 1993. PMID: 7678283 Review. No abstract available.
• The classification of 5-hydroxytryptamine receptors.

  Leff P, Martin GR. Leff P, et al. Med Res Rev. 1988 Apr-Jun;8(2):187-202. doi: 10.1002/med.2610080203. Med Res Rev. 1988. PMID: 3288820 Review. No abstract available.